ALZAI Health Corp. Announces Validation of Its AI-Driven Alzheimers Disease Risk Screening Solution on Large-Scale U.S. Patient Data

ALZAI Health Corp. (TSXV: ALZI) ("ALZAI" or the "Company"), is pleased to announce the validation of its proprietary artificial intelligence-driven Alzheimer's disease risk identification models using ...
UC San Francisco

Improving Prediction of Alzheimer’s Disease with AI

Millions of people are diagnosed with Alzheimer’s disease each year, comprising 60% to 70% of dementia cases worldwide. While cognitive impairment and structural brain changes are indicative of ...
Medical Xpress

AI models comb patient data to predict cardiac arrest risk

Researchers have developed artificial intelligence (AI) models that can scrutinize electronic health records (EHR) and electrocardiograms to identify individuals in the general population at elevated ...
TCTMD

AI-ECG Models Detect Structural Heart Disease, Identify At-Risk Patients

The tools may help address underdiagnosis in this area, though there is still room for improvement in screening performance.
Medical Xpress

A machine learning model may enable liver cancer risk prediction with routine clinical information

A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test results predicted a patient's risk of hepatocellular carcinoma (HCC), the most common ...

First AI agent and risk prediction model for precision diabetes management

A research team at The Hong Kong Polytechnic University (PolyU) has developed Hong Kong's first "AI Agent for Precision ...

AI tool improves prediction of who will respond to cancer immunotherapy drugs

Cancer immunotherapy drugs known as immune checkpoint inhibitors (ICIs) can be miracle drugs for cancer patients, curing some ...
ascopubs.org

Recurrence risk prediction using a large, multi-site observational dataset of patients with early breast cancer, including early-onset disease.

AI-based pre-screening of BRCA1/2 mutation likelihood from routine H&E histopathology in unselected breast cancer cases using peakPredictBRCA. This is an ASCO Meeting Abstract from the 2026 ASCO ...

Alzai Health Corp.: ALZAI Health Corp. Announces Validation of Its AI-Driven Alzheimers Disease Risk Screening Solution on Large-Scale U.S. Patient Data

ALZAI Health Corp. (TSXV: ALZI) ("ALZAI" or the "Company"), is pleased to announce the validation of its proprietary artificial intelligence-driven ...